Cambridge Polymer Group, Inc Company Profile

19:37 EDT 24th March 2018 | BioPortfolio

Cambridge Polymer Group, Inc. is a contract research laboratory located in Boston, MA. The company was founded in 1996 by MIT doctoral recipients to provide a cost-effective resource for research and development to clients who need periodic access to Ph.D.-level scientists and their support structure. Our think-tank style of research allows our scientists to assist in the development of new materials, formulations and instrumentation in response to client-specified requirements. When designing solutions, we actively consider the full-range of relevant parameters including manufacturing constraints, quality control, intellectual property strategies, and compliance with federal regulatory agencies. Our researchers are experts in a broad range of scientific fields, including chemical, electrical, biomedical and mechanical engineering, materials science and biology. These disciplines are coupled with experience in prototyping, manufacturing, equipment design, marketing, and intellectual property to deliver results with academic-thoroughness in a cost-efficient, clear and timely manner. Our core competencies include property enhancement and development, test methodology development, process development, radiation chemistry, rheology, failure analysis and blends formulations. Consequently our clients are from a range of industries including orthopedics manufacturers , cardiovascular catheter design, ophthalmological biomaterials , resin manufacturers and processors, consumer products, gels, adhesives, food products, and inks.


52-R Roland St
United States of America


Phone: (617) 629-4400
Fax: (617) 629-9100

News Articles [903 Associated News Articles listed on BioPortfolio]

Cambridge Analytica Suspends CEO After Alarming Reports On Its Election Maneuvers

Cambridge Analytica, the British political research group linked to President

#jobs #lifescience Sr Administrative Assistant at Pharma/Biotech in Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr Administrative Assistant at Pharma/Biotech in Cambridge .MA-Cambridge, Sr ...

Creative Diagnostics Introduces Polymer Particles for Researchers

With years of experience in the pharmaceutical and life sciences sector, Creative Diagnostics launches a large selection of high quality Polymer Particles with multiple sizes from 20 nm to 100 &m...

Cambridge Combinatorial Completes Collaboration With Dainippon Pharmaceutical; Expands Lab Facilities

Cambridge Combinatorial Ltd., a wholly owned subsidiary of Oxford Molecular Group, has completed delivery of library compounds in their collaboration with Dainippon Pharmaceutical Co. Ltd., a Japanese...

Global Polymer Films Market Data Survey Report 2025 [Report Updated: 06122017] Prices from USD $1500

SummaryThe global Polymer Films market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, prod...

[Articles] A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phas

The sirolimus-eluting bioabsorbable polymer stent was non-inferior to the everolimus-eluting durable polymer stent for a device-oriented composite clinical endpoint at 12 months in an all-comer popula...

American National Bank Has Cut American Airlines Group (AAL) Holding; ...

American National Bank Has Cut American Airlines Group Holding; Cambridge Financial Group Trimmed By $2.42 Billion Its Nvidia Stake American National Bank decreased American Airlines Group stake by 14...

Global Polymer Films Market Analysis 20112017 and Forecast 20182023 [Report Updated: 21112017] Prices from USD $2980

SnapshotThe global Polymer Films market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then ...

PubMed Articles [3082 Associated PubMed Articles listed on BioPortfolio]

Simultaneous crystallization of an in situ formed conjugated polymer and inorganic matrix for structure solving.

Here, we have, for the first time, reported the crystal structure of a conjugated polymer-inorganic composite by encapsulating conjugated polymer chains into a porous bromoplumbate matrix. The photoel...

Polymer nanodiscs and macro-nanodiscs of a varying lipid composition.

Polymer lipid nanodiscs have enabled some exciting structural biology and nanobiotechnology applications. The use of a small molecular weight polymer (SMA-EA) has been demonstrated to dramatically inc...

Mechano-, thermo-, solvato-, and vapochromism in bis(acetato-κ(1)O)4'-(4-(diphenylamino)phenyl)(2,2':6',2''-terpyridine-κ(3)N,N',N'')zinc(ii) and its polymer.

The titled complex exhibits multi-functional luminochromism in the solid state, despite its simple chemical structure. The complex shows solid-state vapochromism and mechanochromism. The polymer analo...

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.

To report long-term safety and efficacy of the biodegradable polymer-coated biolimus-eluting Nobori stent compared to the durable polymer-coated sirolimus-eluting Cypher stent.

Comparison Between Two Biodegradable Polymer-Based Sirolimus-Eluting Stents with Differing Drug Elution and Polymer Absorption Kinetics: Two-Year Clinical Outcomes of the PANDA III Trial.

In PANDA III trial, the novel poly-lactide-co-glycolide polymer-based BuMA sirolimus-eluting stent (SES) was non-inferior to the polylactide polymer-based Excel SES for the primary endpoint of 1-year ...

Clinical Trials [3652 Associated Clinical Trials listed on BioPortfolio]

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

The purpose of this study is to evaluate the efficacy of 3 different rapamycin-eluting-stent platforms to reduce coronary artery reblockage after stent implantation

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents

The aim of this prospective, randomized study is to compare the efficacy and safety of biodegradable polymer based limus-eluting stents (BPDES) with permanent polymer based everolimus elut...

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography

The objective of the study is to assess the superiority of the biodegradable polymer based limus-eluting stents (ISAR G2, Nobori®) compared with the permanent polymer based everolimus-elu...

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

The introduction of drug-eluting stents (DES) in the treatment of coronary artery disease has led to a significant reduction in morbidity. However, the first generation of these devices ha...

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent

PONTINA aims at assessing by optical coherence tomography the neointimal coverage of the biodegradable polymer-based Biolimus A9-eluting stent (Biomatrix stent) after full drug elution and...

Companies [2123 Associated Companies listed on BioPortfolio]

Icon Polymer Group Ltd

The Icon Polymer Group is a world class global provider of technically complex and innovative elastomer solutions across a broad spectrum of industries requiring a versatile, viable and market-centred...

The Cambridge Group

The Cambridge Group ( is a strategy consulting firm focused on the development of growth strategies for Fortune 500 companies. For over 30 years, The Cambridge Gr...

The Cambridge Group Ltd

The Cambridge Group Ltd was founded in 1976. The firm has enjoyed over 29 years of steady growth and serves a diverse clientele with specialty practice areas in Information Systems, Pharmaceuticals, a...

Polymer Laboratories

Polymer Laboratories develops techniques and instrumentation for the characterization of polymer systems, and develops high technology polymer products for liquid chromatography, diagnostic and pharma...

Cambridge Polymer Group, Inc

Cambridge Polymer Group, Inc. is a contract research laboratory located in Boston, MA. The company was founded in 1996 by MIT doctoral recipients to provide a cost-effective resource for research and ...

More Information about "Cambridge Polymer Group, Inc" on BioPortfolio

We have published hundreds of Cambridge Polymer Group, Inc news stories on BioPortfolio along with dozens of Cambridge Polymer Group, Inc Clinical Trials and PubMed Articles about Cambridge Polymer Group, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Polymer Group, Inc Companies in our database. You can also find out about relevant Cambridge Polymer Group, Inc Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record